Literature DB >> 22180673

Vaccination: the present and the future.

Saheli Sadanand1.   

Abstract

Vaccines have undoubtedly saved the lives of millions, and along with improved sanitation, they remain one of the cornerstones of modern medicine. Many diseases that were once widespread are now eradicated, but vaccine programs face ongoing challenges. Safety concerns as well as limited funding have led to pockets of reduced vaccine coverage around the world - including in developed countries. Chronic and recurrent diseases such as human immunodeficiency virus (HIV), tuberculosis, and malaria remain without effective vaccines. This review will briefly describe vaccines and the two major issues faced by modern vaccination programs: insufficient vaccine coverage and developing effective vaccines for chronic and recurrent diseases.

Entities:  

Keywords:  HIV; chronic infections; immunological memory; malaria; tuberculosis; vaccine safety; vaccines

Mesh:

Substances:

Year:  2011        PMID: 22180673      PMCID: PMC3238332     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  23 in total

1.  Therapeutic vaccines: realities of today and hopes for tomorrow.

Authors:  Michael Sela; Maurice R Hilleman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

Review 2.  How do adjuvants work? Important considerations for new generation adjuvants.

Authors:  Amy S McKee; Michael W Munks; Philippa Marrack
Journal:  Immunity       Date:  2007-11       Impact factor: 31.745

3.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor.

Authors:  Nikhil S Joshi; Weiguo Cui; Anmol Chandele; Heung Kyu Lee; David R Urso; James Hagman; Laurent Gapin; Susan M Kaech
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

4.  Measles epidemic in the Netherlands, 1999-2000.

Authors:  Susan van den Hof; Marina A E Conyn-van Spaendonck; Jim E van Steenbergen
Journal:  J Infect Dis       Date:  2002-10-29       Impact factor: 5.226

5.  Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial.

Authors:  Mark Loeb; Margaret L Russell; Lorraine Moss; Kevin Fonseca; Julie Fox; David J D Earn; Fred Aoki; Gregory Horsman; Paul Van Caeseele; Khami Chokani; Mark Vooght; Lorne Babiuk; Richard Webby; Stephen D Walter
Journal:  JAMA       Date:  2010-03-10       Impact factor: 56.272

6.  Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome.

Authors:  Shruti Sharma; Rosane B DeOliveira; Parisa Kalantari; Peggy Parroche; Nadege Goutagny; Zhaozhao Jiang; Jennie Chan; Daniella C Bartholomeu; Fanny Lauw; J Perry Hall; Glen N Barber; Ricardo T Gazzinelli; Katherine A Fitzgerald; Douglas T Golenbock
Journal:  Immunity       Date:  2011-08-04       Impact factor: 31.745

7.  Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa.

Authors:  Laith J Abu-Raddad; Padmaja Patnaik; James G Kublin
Journal:  Science       Date:  2006-12-08       Impact factor: 47.728

8.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

Authors:  A J Wakefield; S H Murch; A Anthony; J Linnell; D M Casson; M Malik; M Berelowitz; A P Dhillon; M A Thomson; P Harvey; A Valentine; S E Davies; J A Walker-Smith
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

9.  Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax.

Authors:  Jiraprapa Wipasa; Chaisuree Suphavilai; Lucy C Okell; Jackie Cook; Patrick H Corran; Kanitta Thaikla; Witaya Liewsaree; Eleanor M Riley; Julius Clemence R Hafalla
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

Review 10.  B-cell responses to vaccination at the extremes of age.

Authors:  Claire-Anne Siegrist; Richard Aspinall
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

View more
  6 in total

1.  AVPpred: collection and prediction of highly effective antiviral peptides.

Authors:  Nishant Thakur; Abid Qureshi; Manoj Kumar
Journal:  Nucleic Acids Res       Date:  2012-05-25       Impact factor: 16.971

Review 2.  Immunogenicity of infectious pathogens and vaccine antigens.

Authors:  Siddhartha Mahanty; Antoine Prigent; Olivier Garraud
Journal:  BMC Immunol       Date:  2015-05-29       Impact factor: 3.615

3.  Design Variation of a Dual-Antigen Liposomal Vaccine Carrier System.

Authors:  Roozbeh Nayerhoda; Andrew Hill; Marie Beitelshees; Charles Jones; Blaine Pfeifer
Journal:  Materials (Basel)       Date:  2019-09-01       Impact factor: 3.623

4.  Control of COVID-19 Outbreaks under Stochastic Community Dynamics, Bimodality, or Limited Vaccination.

Authors:  Björn Goldenbogen; Stephan O Adler; Oliver Bodeit; Judith A H Wodke; Ximena Escalera-Fanjul; Aviv Korman; Maria Krantz; Lasse Bonn; Rafael Morán-Torres; Johanna E L Haffner; Maxim Karnetzki; Ivo Maintz; Lisa Mallis; Hannah Prawitz; Patrick S Segelitz; Martin Seeger; Rune Linding; Edda Klipp
Journal:  Adv Sci (Weinh)       Date:  2022-05-23       Impact factor: 17.521

5.  The average IFN-γ secreting capacity of specific CD8(+) T cells is compromised while increasing copies of a single T cell epitope encoded by DNA vaccine.

Authors:  Yanmin Wan; Jing Wang; Haizhu Zhou; Zhidong Hu; Xiaonan Ren; Jianqing Xu
Journal:  Clin Dev Immunol       Date:  2012-11-01

6.  AVP-IC50 Pred: Multiple machine learning techniques-based prediction of peptide antiviral activity in terms of half maximal inhibitory concentration (IC50).

Authors:  Abid Qureshi; Himani Tandon; Manoj Kumar
Journal:  Biopolymers       Date:  2015-11       Impact factor: 2.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.